The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS Journal Article


Authors: Li, C.; Vides, A.; Kim, D.; Xue, J. Y.; Zhao, Y.; Lito, P.
Article Title: The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS
Abstract: Recently reported to be effective in patients with lung cancer, KRASG12C inhibitors bind to the inactive, or guanosine diphosphate (GDP)-bound, state of the oncoprotein and require guanosine triphosphate (GTP) hydrolysis for inhibition. However, KRAS mutations prevent the catalytic arginine of GTPase-activating proteins (GAPs) from enhancing an otherwise slow hydrolysis rate. If KRAS mutants are indeed insensitive to GAPs, it is unclear how KRASG12C hydrolyzes sufficient GTP to allow inactive state-selective inhibition. Here, we show that RGS3, a GAP previously known for regulating G protein-coupled receptors, can also enhance the GTPase activity of mutant and wild-type KRAS proteins. Our study reveals an unexpected mechanism that inactivates KRAS and explains the vulnerability to emerging clinically effective therapeutics. © 2021 American Association for the Advancement of Science. All rights reserved.
Keywords: mutation; protein; enzyme activity; inhibitor; hydrolysis; inhibition
Journal Title: Science
Volume: 374
Issue: 6564
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2021-10-08
Start Page: abf1730
Language: English
DOI: 10.1126/science.abf1730
PROVIDER: scopus
PUBMED: 34618566
PMCID: PMC9295010
DOI/URL:
Notes: Article -- Export Date: 2 November 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Piro Lito
    58 Lito
  2. Yaohua Xue
    13 Xue
  3. Alberto Vides
    8 Vides
  4. Yulei Zhao
    8 Zhao
  5. Dongsung Kim
    8 Kim
  6. Chuanchuan Li
    7 Li